About Us
Our Mission
Company Profile
Executive Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
ProTcell platform
Pipeline
News
Press releases
Smart Stories
Partnering
Contact
January 22, 2020
[Media coverage] A l’hôpital Necker, une start-up mise sur un traitement post-greffe innovant
Voir l’article sur le Monde
Download the article (FR)
Download the article (GR)
Latest news
Browse all
Smart Immune to Present ReSet-02 Phase I Preliminary Data and the Determination of the Recommended Dose at ASH 2024
November 5, 2024
Smart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept Trials
October 23, 2024